Bolt Biotherapeutics, Inc. · NASDAQ:BOLT
Tang Capital Management LLC reported a 8.70% stake in Bolt Biotherapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Tang Capital Management LLC reported a 8.70% stake in Bolt Biotherapeutics, Inc., 166,879 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 8.70%
- Shares
- 166,879
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 8.70% | 166,879 |
| KEVIN TANG | 8.70% | 166,879 |
| TANG CAPITAL PARTNERS, LP | 4.90% | 93,913 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.80% | 72,966 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Bolt Biotherapeutics, Inc.
- Tang Capital Management LLC
- Bolt Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Nov 14, 2025
- Schedule 13G/A · Tang Capital Management LLC · Nov 14, 2025
- Form 4 · Yonehiro Grant · Sep 21, 2026
- Form 4 · Nemec Sarah · Sep 21, 2026
- Form 4 · Quinn William P. · Sep 21, 2026
- Schedule 13G · Renaissance Technologies LLC · Aug 13, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 26, 2026